Morphomics predicts response to ipilimumab in patients with stage IV melanoma. uri icon

authors

  • Sabel, Michael S
  • Jay Lee, MD
  • Wang, Anran
  • Lao, Christopher
  • Holcombe, Sven
  • Wang, Stewart

publication date

  • August 7, 2015